Investment Rating - The report gives a "Cautious Recommendation" rating for the company, marking its first coverage [6]. Core Insights - The controlling shareholder, Hengtong Group, has injected a copper foil business into the company, which is expected to drive future growth. Hengtong Group plans to increase its stake in the company by investing between 150 million to 300 million yuan over the next 12 months, reflecting confidence in the company's future [1][15]. - The company is focusing on high-end electronic copper foil products, which are expected to see significant demand growth driven by AI applications. The company has developed advanced copper foil products, including 6-micron and 4.5-micron copper foils, and has successfully replaced imported products with its own [2][50]. - The company plans to invest in a new amino acid production base to strengthen its traditional business, particularly in feed additives. The amino acid market in China is projected to grow significantly, with a focus on L-tryptophan and other essential amino acids [3][19]. Summary by Sections 1. Hengtong Group's Strength and Business Transformation - The company, founded in 1993, initially focused on veterinary medicine and pesticides. After Hengtong Group became the controlling shareholder in 2022, the company began a significant transformation, including the acquisition of a copper foil business [11][12]. - Hengtong Group is a leading enterprise in China, ranked among the top 500 companies and top 100 private enterprises, with a strong presence in the global fiber optic and marine communication sectors [13][14]. 2. Electrolytic Copper Foil: High Demand from AI - Electrolytic copper foil is a crucial raw material for printed circuit boards (PCBs) and lithium-ion batteries. The company is focusing on high-end electronic copper foil to capitalize on the growing demand driven by AI applications [26][32]. - The demand for high-end copper foil is expected to increase significantly due to the high-frequency and high-speed transmission requirements of AI and 5G applications [50][39]. 3. Feed Additives and Traditional Business - The company is planning to build a new amino acid production base, which will enhance its product offerings in the feed additive sector. The market for feed amino acids in China is expected to grow substantially, with a focus on L-tryptophan [3][19]. - The company’s traditional businesses, including veterinary medicine and pesticides, have maintained stable growth, while the copper foil business is expected to drive a rebound in overall performance [19][21]. 4. Financial Forecast and Investment Recommendations - The company is projected to achieve revenues of 1.305 billion, 1.724 billion, and 2.025 billion yuan in 2024, 2025, and 2026, respectively, with corresponding net profits of 230 million, 279 million, and 356 million yuan [5]. - The report anticipates a PE ratio of 36, 30, and 23 for the years 2024, 2025, and 2026, respectively, indicating a positive outlook for the company's financial performance [5].